arrow_back Back to App

New Restrictions on Abortion Drugs: In-Person Dispensing and Safety Rules

This bill prohibits the FDA from approving any new abortion drugs or granting investigational use exemptions for them. For previously approved drugs, it mandates strict requirements, requiring the medication to be dispensed only in person by the prescribing healthcare practitioner at a clinic, medical office, or hospital, prohibiting pharmacy dispensing. Prescribing practitioners must have the ability to diagnose ectopic pregnancies and provide surgical intervention in cases of incomplete abortion or severe bleeding.
Key points
The FDA is prohibited from approving any new abortion drugs or granting investigational use exemptions for such drugs.
Abortion drugs must be dispensed to the patient in person by the prescribing practitioner in a clinic, medical office, or hospital; pharmacy dispensing is prohibited.
Prescribing practitioners must be certified and have the ability to provide surgical intervention in cases of incomplete abortion or severe bleeding.
The FDA is prohibited from approving labeling changes to allow the use of abortion drugs after 70 days gestation.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_95
Sponsor: Sen. Hyde-Smith, Cindy [R-MS]
Process start date: 2023-01-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

SAVE Moms and Babies Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_95.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-01-26.

What are the main provisions?

Key points include:

  • The FDA is prohibited from approving any new abortion drugs or granting investigational use exemptions for such drugs.
  • Abortion drugs must be dispensed to the patient in person by the prescribing practitioner in a clinic, medical office, or hospital; pharmacy dispensing is prohibited.
  • Prescribing practitioners must be certified and have the ability to provide surgical intervention in cases of incomplete abortion or severe bleeding.
  • The FDA is prohibited from approving labeling changes to allow the use of abortion drugs after 70 days gestation.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hyde-Smith, Cindy [R-MS].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

CATEGORIES

Health Family